1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden.
Saved in:
| Title: | 1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden. |
|---|---|
| Authors: | Singh, S.1 (AUTHOR), Capdevila, J.2 (AUTHOR), Halfdanarson, T.R.3 (AUTHOR), Halperin, D.4 (AUTHOR), Herrmann, K.5 (AUTHOR), Pavel, M.E.6 (AUTHOR), Xu, J.7 (AUTHOR), Pathak, D.8 (AUTHOR), Kunz, P.L.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1020-S1020. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
